Article of the Week

From Dancing to Debilitated

From Dancing to Debilitated

Posted by  | Article of the Week

ARTICLE: From Dancing to Debilitated AUTHORS: Brian A. Houston, P. Elliott Miller, Lisa M. Rooper, Paul J. Scheel, Jr. and Allan C. Gelber JOURNAL: N Engl J Med. 2016 Feb 4;374(5):470-7. doi: 10.1056/NEJMcps1311794 A 69-year-old man sought care from his primary care physician for fatigue and an unintentional weight loss of 14 kg over the preceding(...)

Read More

Quantitative IFN-γ,IL-2 Response and Latent Tuberculosis Test Discordance in HIV-infected Pregnant Women

Quantitative IFN-γ,IL-2 Response and Latent Tuberculosis Test Discordance in HIV-infected Pregnant Women

Posted by  | Article of the Week

ARTICLE: Quantitative IFN-γ,IL-2 Response and Latent Tuberculosis Test Discordance in HIV-infected Pregnant Women AUTHORS: Jyoti S Mathad, Ramesh Bhosale, Usha Balasubramanian, Savita Kanade, Vidya Mave, Nishi Suryavanshi, Nikhil Gupte, Samir Joshi, Ajay Chandanwale, Kathryn M Dupnik, Vandana Kulkarni, Prasad Deshpande, Daniel W Fitzgerald and Amita Gupta JOURNAL: Am J Respir Crit Care Med. 2016 Jan 14. [Epub ahead of print] Abstract RATIONALE: Pregnant women with latent TB infection (LTBI) are at high risk(...)

Read More

Toward Earlier Inclusion of Pregnant and Postpartum Women in Tuberculosis Drug Trials: Consensus Statements From an International Expert Panel

Toward Earlier Inclusion of Pregnant and Postpartum Women in Tuberculosis Drug Trials: Consensus Statements From an International Expert Panel

Posted by  | Article of the Week

ARTICLE: Toward Earlier Inclusion of Pregnant and Postpartum Women in Tuberculosis Drug Trials: Consensus Statements From an International Expert Panel AUTHORS: Gupta A, Mathad JS, Abdel-Rahman SM, Albano JD, Botgros R, Brown V, Browning RS, Dawson L, Dooley KE, Gnanashanmugam D, Grinsztejn B,Hernandez-Diaz S, Jean-Philippe P, Kim P, Lyerly AD, Mirochnick M, Mofenson LM, Montepiedra G, Piper J, Sahin L, Savic R, Smith B,Spiegel H, Swaminathan S, Watts DH, White A JOURNAL: Clin Infect Dis. 2015 Dec(...)

Read More

Real cost of outrageous drug prices: Column

Real cost of outrageous drug prices: Column

Posted by  | Article of the Week

ARTICLE: Real cost of outrageous drug prices: Column AUTHORS: Leah Dickstein, Rachel Kruzan and Annie Antar JOURNAL: USA Today In 1996, Reva Jones’ daughter, Tonya, gave her the ultimate gift — a kidney that would save her life. Like all transplant recipients, Reva would have to take medications for the rest of her life to protect(...)

Read More

Pacemaker-induced transient asynchrony suppresses heart failure progression

Pacemaker-induced transient asynchrony suppresses heart failure progression

Posted by  | Article of the Week

ARTICLE: Pacemaker-induced transient asynchrony suppresses heart failure progression AUTHORS: Kirk JA, Chakir K, Lee KH, Karst E, Holewinski RJ, Pironti G, Tunin RS, Pozios I, Abraham TP, de Tombe P, Rockman HA, Van Eyk JE, Craig R, Farazi TG, Kass DA JOURNAL: Sci Transl Med. 2015 Dec 23;7(319):319ra207. doi: 10.1126/scitranslmed.aad2899. Abstract Uncoordinated contraction from electromechanical delay worsens heart failure pathophysiology and prognosis, but restoring coordination with biventricular pacing, known as cardiac resynchronization(...)

Read More

Why I Believe in Hospital at Home

Why I Believe in Hospital at Home

Posted by  | Article of the Week

ARTICLE: Why I Believe in Hospital at Home AUTHOR: Bruce Leff JOURNAL: N Engl Med. 2015 Dec 21 As a medical resident in the late 1980s, I made house calls to homebound older adults in Baltimore. I loved seeing patients and their families in their own space, thinking about their medical issues in that context,(...)

Read More

O-GlcNAcomic profiling identifies widespread O-GlcNAcylation in oxidative phosphorylation system regulating cardiac mitochondrial function

O-GlcNAcomic profiling identifies widespread O-GlcNAcylation in oxidative phosphorylation system regulating cardiac mitochondrial function

Posted by  | Article of the Week

For our final Article of the Week of 2015, we feature a collaborative effort between Brian O’Rourke’s and Gerald Hart’s labs that was recently named one of the Journal of Biological Chemisty’s best of 2015. To see all of the 16 papers to receive this distinction, click here: http://www.jbc.org/content/290/49/29141.long ARTICLE: O-GlcNAcomic profiling identifies widespread O-GlcNAcylation(...)

Read More

Trends in National Institutes of Health Funding for Clinical Trials Registered in ClinicalTrials.gov

Trends in National Institutes of Health Funding for Clinical Trials Registered in ClinicalTrials.gov

Posted by  | Article of the Week

ARTICLE: Trends in National Institutes of Health Funding for Clinical Trials Registered in ClinicalTrials.gov AUTHORS: Ehrhardt S, Appel LJ, Meinert CL JOURNAL: JAMA. 2015 Dec 15;314(23):2566-7. doi: 10.1001/jama.2015.12206 Since 2006, the number of industry-sponsored clinical trials studying the benefits and harms of medical treatments has risen dramatically, while the number of clinical trials funded by the National Institutes of Health (NIH) has fallen substantially, according to new Johns(...)

Read More

Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research

Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research

Posted by  | Article of the Week

ARTICLE: Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research AUTHORS: Adler RA, Fuleihan GE, Bauer DC, Camacho PM, Clarke BL, Clines GA, Compston JE, Drake MT, Edwards BJ, Favus MJ, Greenspan SL, McKinney R Jr, Pignolo RJ, Sellmeyer DE JOURNAL: J Bone Miner Res. 2015 Sep 9. doi: 10.1002/jbmr.2708. [Epub ahead of print] Abstract Bisphosphonates(...)

Read More

Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection

Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection

Posted by  | Article of the Week

ARTICLE: Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection AUTHORS: Foster GR, Afdhal N, Roberts SK, Bräu N, Gane EJ, Pianko S, Lawitz E, Thompson A, Shiffman ML, Cooper C, Towner WJ, Conway B, Ruane P, Bourlière M,Asselah T, Berg T, Zeuzem S, Rosenberg W, Agarwal K, Stedman CA, Mo H, Dvory-Sobol H, Han L, Wang J, McNally J, Osinusi A, Brainard DM, McHutchison JG, Mazzotta F, Tran TT, Gordon SC, Patel K, Reau N, Mangia A, Sulkowski M; ASTRAL-2 and ASTRAL-3 Investigators JOURNAL: N Engl J(...)

Read More